Ahmed Al-Mukhtar

Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trial

Paula Ghaneh, Daniel H. Palmer, Silvia Cicconi et al. · ˜The œLancet. Gastroenterology & hepatology · 2022 · 325 citations · Full text

Medicine, Oncology, Surgery +16

Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study

James Glasbey, Adesoji Ademuyiwa, Adewale Adisa et al. · The Lancet Oncology · 2021 · 289 citations · Full text

Medicine, Oncology, Surgery +11

Elective Cancer Surgery in COVID-19–Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study

James Glasbey, Dmitri Nepogodiev, Joana Simões et al. · Journal of Clinical Oncology · 2020 · 222 citations · Full text

Medicine, Oncology, Surgery +11

Preoperative Prognostic Score for Predicting Survival After Hepatic Resection for Colorectal Liver Metastases

Hassan Malik, Rajendra Prasad, Karim J. Halazun et al. · Annals of Surgery · 2007 · 211 citations

Medicine, Oncology, Surgery +17

ESPAC-5F: Four-arm, prospective, multicenter, international randomized phase II trial of immediate surgery compared with neoadjuvant gemcitabine plus capecitabine (GEMCAP) or FOLFIRINOX or chemoradiotherapy (CRT) in patients with borderline resectable pancreatic cancer.

Paula Ghaneh, Daniel H. Palmer, Silvia Cicconi et al. · Journal of Clinical Oncology · 2020 · 164 citations

Medicine, Oncology, Surgery +13